trial_id	eligibility_criteria
ACTRN12613000198729	catype:Ewing sarcoma
ACTRN12613000198729	catype:Osteosarcoma
ACTRN12613000198729	catype:Sarcoma
ACTRN12613000198729	catype:Small-cell lung cancer
ACTRN12613000198729	catype:Triple-negative breast cancer
ACTRN12613000198729	catype:melanoma
ACTRN12617000741381	TRANSPLANT_RELATED_CANCERS
ACTRN12617001190392	NOT KRAS:oncogenic_mutation; NOT NRAS:oncogenic_mutation
ACTRN12617001325392	ERBB2:amplification
ACTRN12617001573347	NOT catype:Glioblastoma
ACTRN12619001265167	NOT catype:Non-small cell lung cancer; (ERBB2:amplification OR ERBB2:overexpression OR ERBB2:oncogenic_mutation); NOT catype:Breast cancer; NOT catype:Gastric adenocarcinoma; NOT catype:Gastric cancer; NOT catype:Gastroesophageal adenocarcinoma; *NOT_RECRUITING
ACTRN12619001265167	catype:Non-small cell lung cancer; (ERBB2:amplification OR ERBB2:overexpression OR ERBB2:oncogenic_mutation); *NOT_RECRUITING
ACTRN12618000233224	NOT_RECRUITING; NOT BRAF:V600E; NOT KRAS:oncogenic_mutation; NOT NRAS:oncogenic_mutation
ACTRN12618000281291	*NOT catype:Basal Cell Carcinoma; *NOT prior_therapy:Vismodegib
ACTRN12618000357257	catype:Angiosarcoma; NOT_RECRUITING
ACTRN12619000844145	ALK:fusion
ACTRN12619001117101	PIK3CA:oncogenic_mutation; NOT ERBB2:amplification; NOT ERBB2:overexpression; *NOT prior_therapy:Fulvestrant
ACTRN12619001185156	*(CCNE1:amplification OR CCNE1:overexpression); *catype:High-grade serous carcinoma of the ovary, fallopian tube, and peritoneum; catype:Ovarian cancer
ACTRN12619001527156	(catype:Head and Neck Squamous Cell Carcinoma OR catype:Triple-Negative Breast Cancer OR catype:Adenoid Cystic Carcinoma)
ACTRN12620000568910	(CDK4:oncogenic_mutation OR CDK4:amplification OR CCND1:amplification OR CCND2:amplification OR CCND3:amplification OR CCND1:oncogenic_mutation OR CCND2:oncogenic_mutation OR CCND3:oncogenic_mutation); *NOT catype:Breast cancer; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12620000568910	(CDKN2A:loss-of-function_mutation OR CDKN2A:deletion); *NOT catype:Breast cancer; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12620000568910p	(CDK4:oncogenic_mutation OR CDK4:amplification OR CCND1:amplification OR CCND2:amplification OR CCND3:amplification OR CCND1:oncogenic_mutation OR CCND2:oncogenic_mutation OR CCND3:oncogenic_mutation); *NOT catype:Breast cancer; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12620000568910p	(CDKN2A:loss-of-function_mutation OR CDKN2A:deletion); *NOT catype:Breast cancer; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12620000861954	(BRAF:V600E OR BRAF:V600K OR BRAF:V600_missense_variant); (catype:Solid tumour OR catype:Non-small cell lung cancer); *NOT catype:Colorectal cancer; NOT catype:Melanoma
ACTRN12620000861954p	(BRAF:V600E OR BRAF:V600K OR BRAF:V600_missense_variant); (catype:Solid tumour OR catype:Non-small cell lung cancer); *NOT catype:Colorectal cancer; NOT catype:Melanoma
ACTRN12620000918921	catype:Solid tumour; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; tumour_mutational_burden:high; *NOT_RECRUITING
ACTRN12620000984998	*NOT catype:Chondrosarcoma; NOT_RECRUITING
ACTRN12620000984998	NOT catype:Osteosarcoma; NOT_RECRUITING
ACTRN12620001146987	MYC:alteration
ACTRN12621000284864	(ROS1:fusion OR NTRK1:fusion OR NTRK2:fusion OR NTRK3:fusion)
ACTRN12621000312842	(ALK:fusion OR ALK:oncogenic_mutation)
ACTRN12621000507886	catype:lymphoma; catype:B-cell lymphoma
ACTRN12621000639820	(catype:Endometrial cancer OR catype:Ovarian cancer OR catype:Fallopian tube carcinoma OR catype:Peritneal serous carcinoma OR catype:Endometrial stromal sarcoma OR catype:Uterine leiomyosarcoma OR catype:Granulosa cell tumour)
ACTRN12621000811808	(MET:exon_14_skipping_mutation OR MET:exon_14_deletion)
ACTRN12622000973718	catype:Non-small cell lung cancer; KRAS:G12C
ACTRN12621001436864	BRAF:V600E; NOT KRAS:oncogenic_mutation; STOPPED_EARLY
ACTRN12621001436864	KRAS:oncogenic_mutation; STOPPED_EARLY
ACTRN12621001690842	*NOT catype:Non-small cell lung cancer; NOT catype:Colorectal cancer
ACTRN12620000767909	(ERBB2:amplification OR ERBB2:overexpression OR ERBB2:oncogenic_mutation); *NOT catype:Breast cancer; *NOT catype:Gastric adenocarcinoma; *NOT catype:Gastric cancer; *NOT catype:Gastroesophageal adenocarcinoma; *Cohort full
ACTRN12620000767909	catype:Breast cancer; NOT ERBB2:amplification; ERBB2:oncogenic_mutation; *Cohort full
ACTRN12620000918921	NOT catype:Pancreatic cancer; NOT catype:Bladder cancer; NOT catype:Urothelial carcinoma
NCT02408861	HIV_POSITIVE
NCT02576431	(NTRK1:fusion OR NTRK2:fusion OR NTRK3:fusion OR ROS1:fusion)
NCT02628067	catype:Anal Cancer
NCT02628067	catype:Biliary Tract Cancer
NCT02628067	catype:Cervical Cancer
NCT02628067	catype:Colorectal cancer; NOT microsatellite_instability:high; NOT mismatch_repair:deficient
NCT02628067	catype:Endometrial Carcinoma
NCT02628067	catype:Lung Neuroendocrine Tumor
NCT02628067	catype:Mesothelioma
NCT02628067	catype:Pancreatic Neuroendocrine Tumor
NCT02628067	catype:Salivary Gland Carcinoma
NCT02628067	catype:Small bowel Neuroendocrine Tumor
NCT02628067	catype:Small-Cell Lung Carcinoma
NCT02628067	catype:Thyroid Carcinoma
NCT02628067	catype:Vulvar Cancer
NCT02628067	microsatellite_instability:high
NCT02960022	*prior_therapy:Enzalutamide
NCT03093116	(NTRK1:fusion OR NTRK2:fusion OR NTRK3:fusion OR ROS1:fusion)
NCT03093116	ALK:fusion
NCT03157128	RET:fusion
NCT03157128	RET:oncogenic_mutation; NOT RET:amplification
NCT03175224	(MET:oncogenic_mutation OR MET:alteration)
NCT03178552	*NOT prior_therapy:systemic_therapy
NCT03212404	catype:Classical Hodgkin Lymphoma
NCT03212404	catype:Colorectal Cancer; (microsatellite_instability:high OR mismatch_repair:deficient)
NCT03212404	catype:Colorectal cancer; microsatellite_instability:high
NCT03212404	catype:Colorectal cancer; mismatch_repair:deficient
NCT03212404	catype:Cutaneous Squamous Cell Carcinoma
NCT03212404	catype:Cutaneous squamous cell carcinoma
NCT03212404	catype:Endometrial Cancer
NCT03212404	catype:Head and Neck Cancer
NCT03212404	catype:Head and neck squamous cell carcinoma
NCT03212404	catype:Hodgkin's lymphoma
NCT03212404	catype:Melanoma
NCT03212404	catype:Melanoma
NCT03212404	catype:Merkel Cell Carcinoma
NCT03212404	catype:Merkel cell carcinoma
NCT03212404	catype:Mesothelioma
NCT03212404	catype:Mesothelioma
NCT03212404	catype:Non Hodgkin Lymphoma
NCT03212404	catype:Non-Hodgkin's lymphoma
NCT03212404	catype:Non-Small-Cell Lung Cancer
NCT03212404	catype:Non-small cell lung cancer
NCT03212404	catype:Renal Cell Carcinoma
NCT03212404	catype:Renal cell carcinoma
NCT03212404	catype:Small-Cell Lung Cancer
NCT03212404	catype:Small-cell lung cancer
NCT03212404	catype:Urothelial Carcinoma
NCT03212404	catype:Urothelial carcinoma
NCT03278717	NOT catype:Ovarian clear cell carcinoma; NOT catype:Ovarian carcinosarcoma; NOT catype:Ovarian mucinous carcinoma; catype:Ovarian cancer
NCT03319940	catype:Small-cell lung carcinoma
NCT03337698	catype:Non-small-cell lung cancer; *NOT prior_therapy:systemic_therapy
NCT03337698	catype:Non-small-cell lung cancer; *(prior_therapy:Cisplatin OR prior_therapy:Carboplatin)
NCT03363776	catype:Breast
NCT03363776	catype:Colorectal
NCT03363776	catype:Ovarian
NCT03363776	catype:Pancreatic
NCT03363776	catype:Prostate
NCT03363776	catype:Urothelial carcinoma
NCT03424005	NOT ERBB2:amplification
NCT03486873	EXTENSION_STUDY
NCT03497767	EGFR:oncogenic_mutation
NCT03551626	BRAF:V600_missense_variant
NCT03674567	catype:Cervical cancer
NCT03674567	catype:Gastric cancer
NCT03674567	catype:Head and neck squamous cell carcinoma
NCT03674567	catype:Hodgkin lymphoma
NCT03674567	catype:Nasopharyngeal carcinoma
NCT03674567	catype:Non-small cell lung cancer
NCT03674567	catype:Oesophageal carcinoma
NCT03674567	catype:Triple-negative breast cancer
NCT03674567	catype:Urothelial carcinoma
NCT03739710	catype:NSCLC
NCT03742895	NOT catype:Ovarian cancer; NOT catype:Breast cancer; (BRCA1:oncogenic_mutation OR BRCA2:oncogenic_mutation)
NCT03742895	catype:Breast cancer; NOT BRCA1:oncogenic_mutation; NOT BRCA2:oncogenic_mutation
NCT03742895	catype:Ovarian cancer; NOT BRCA1:oncogenic_mutation; NOT BRCA2:oncogenic_mutation
NCT03821935	catype:Head and neck squamous cell carcinoma
NCT03821935	catype:Hepatocellular carcinoma
NCT03821935	catype:Pancreatic adenocarcinoma
NCT03821935	catype:Triple-negative breast cancer
NCT03821935	catype:Urothelial cancer
NCT03878719	BRAF:V600_missense_variant
NCT03905148	*NOT catype:CNS cancer
NCT03906331	RET:fusion; *Expanded access program
NCT03906331	RET:oncogenic_mutation; NOT RET:amplification; *Expanded access program
NCT03947385	(GNAQ:oncogenic_mutation OR GNA11:oncogenic_mutation OR PRKC:fusion)
NCT03974022	(ERBB2:oncogenic_mutation OR EGFR:oncogenic_mutation)
NCT03975647	(ERBB2:amplification OR ERBB2:overexpression OR ERBB2:protein_expression)
NCT04008030	(MSI:H OR MMR:deficient)
NCT04064060	NOT catype:solid tumours
NCT04161885	catype:Acute Myeloid Leukemia
NCT04164199	access:by_invitation_only
NCT04170283	NOT catype:solid tumours
NCT04185883	KRAS:G12C
NCT04191499	catype:Breast cancer; NOT ERBB2:amplification; PIK3CA:alteration; *NOT_RECRUITING
NCT04222972	catype:Non-small cell lung cancer; RET:fusion
NCT04223856	*NOT prior_therapy:systemic_therapy
NCT04249843	(BRAF:alteration OR KRAS:alteration OR NRAS:alteration); NOT catype:Colorectal cancer; NOT catype:Pancreatic cancer; COHORT1_HAS_CLOSED
NCT04249843	BRAF:alteration; BRAF:V600E; catype:Melanoma
NCT04249843	BRAF:alteration; BRAF:V600E; catype:Non-small cell lung carcinoma
NCT04249843	BRAF:alteration; NOT BRAF:V600E
NCT04249843	NOT catype:Colorectal cancer; BRAF:V600E; prior_therapy:BRAF_V600_inhibitor
NCT04249843	catype:Solid tumour; BRAF:class_2_mutation
NCT04251117	catype:Hepatocellular carcinoma
NCT04269200	NOT catype:Leiomyosarcoma
NCT04277637	NOT catype:solid tumours
NCT04282018	catype:Cervical cancer
NCT04282018	catype:Endometrial carcinoma
NCT04282018	catype:Gastric cancer
NCT04282018	catype:Gastroesophageal junction carcinoma
NCT04282018	catype:Haematologic cancer
NCT04282018	catype:Head and neck squamous cell carcinoma
NCT04282018	catype:Hepatocellular carcinoma
NCT04282018	catype:Melanoma
NCT04282018	catype:Nasopharyngeal carcinoma
NCT04282018	catype:Non-small cell lung cancer
NCT04282018	catype:Oesophageal cancer
NCT04282018	catype:Ovarian cancer
NCT04282018	catype:Renal cell carcinoma
NCT04282018	catype:Small cell lung cancer
NCT04282018	catype:Triple-negative breast cancer
NCT04282018	catype:Urothelial carcinoma
NCT04282018	microsatellite_instability:high
NCT04282018	mismatch_repair:deficient
NCT04311710	catype:Hepatocellular carcinoma
NCT04311710	catype:Melanoma
NCT04311710	catype:Non-small cell lung cancer
NCT04311710	catype:Renal cell carcinoma
NCT04311710	catype:Urothelial carcinoma
NCT04417621	catype:Melanoma; (BRAF:V600_misssense_mutation OR NRAS:oncogenic_mutation)
NCT04427072	MET:exon_14_skipping_mutation
NCT04434482	NOT catype:central nervous system cancer
NCT04449874	KRAS:G12C; catype:Colorectal cancer
NCT04449874	KRAS:G12C; catype:Non-small cell lung cancer
NCT04449874	KRAS:G12C; catype:Solid tumour
NCT04450732	(ERBB2:oncogenic_mutation OR ERBB2:amplification OR ERBB2:overexpression)
NCT04516447	(catype:Ovarian cancer OR catype:Fallopian tube carcinoma OR catype:Peritoneal serous carcinoma); *catype:High-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
NCT04565275	(FGFR1:alteration OR FGFR2:alteration OR FGFR3:alteration); *NOT prior_therapy:pan-FGFR_inhibitor
NCT04585035	KRAS:G12C
NCT04589845	*NOT_RECRUITING; (sensitive_to:GDC-0077 OR sensitive_to_drug_class:PI3K_inhibitor); *(PIK3CA:E542_missense_variant OR PIK3CA:E545_missense_variant OR PIK3CA:H1047_missense_variant); *(PIK3CA:E81K OR PIK3CA:E88Q OR PIK3CA:E88P OR PIK3CA:R93Q OR PIK3CA:R93W OR PIK3CA:P104L OR PIK3CA:G106_missense_variant  OR PIK3CA:R108_missense_variant OR PIK3CA:K111_missense_variant  OR PIK3CA:G118_missense_variant OR PIK3CA:N345_missense_variant OR PIK3CA:R357_missense_variant OR PIK3CA:C378_missense_variant OR PIK3CA:C420_missense_variant OR PIK3CA:E453_missense_variant OR PIK3CA:E542_missense_variant OR PIK3CA:E545_missense_variant OR PIK3CA:Q546_missense_variant OR PIK3CA:M1004_missense_variant OR PIK3CA:M1043_missense_variant OR PIK3CA:H1047_missense_variant OR PIK3CA:H1048_missense_variant OR PIK3CA:G1049_missense_variant)
NCT04589845	(sensitive_to:Trastuzumab emtansine OR sensitive_to_drug_class:anti-ERBB2_antibody-drug_conjugate); NOT ERBB2:amplification; *NOT prior_therapy:Trastuzumab emtansine; (ERBB2:G222C OR ERBB2:R226S OR ERBB2:E265K OR ERBB2:D277H OR ERBB2:G292R OR ERBB2:G309A OR ERBB2:G309E OR ERBB2:S310F OR ERBB2:S310Y OR ERBB2:C311R OR ERBB2:C311S OR ERBB2:E321G OR ERBB2:C334S); *NOT_RECRUITING
NCT04589845	(sensitive_to:Trastuzumab emtansine OR sensitive_to_drug_class:anti-ERBB2_antibody-drug_conjugate); NOT ERBB2:amplification; *NOT prior_therapy:Trastuzumab emtansine; (ERBB2:P551L OR ERBB2:R552S OR ERBB2:S418T OR ERBB2:A440T); *NOT_RECRUITING
NCT04589845	(sensitive_to:Trastuzumab emtansine OR sensitive_to_drug_class:anti-ERBB2_antibody-drug_conjugate); NOT ERBB2:amplification; *NOT prior_therapy:Trastuzumab emtansine; (ERBB2:S653C OR ERBB2:V659E OR ERBB2:G660D OR ERBB2:R678Q); *NOT_RECRUITING
NCT04589845	(sensitive_to:Trastuzumab emtansine OR sensitive_to_drug_class:anti-ERBB2_antibody-drug_conjugate); NOT ERBB2:amplification; *NOT prior_therapy:Trastuzumab emtansine; (ERBB2:T733I OR ERBB2:L755P OR ERBB2:L755S OR ERBB2:I767M OR ERBB2:L768S OR ERBB2:D769H OR ERBB2:D769N OR ERBB2:D769Y OR ERBB2:A775_Y776insYVMA OR ERBB2:A775_Y776ins OR ERBB2:L775P OR ERBB2:L775S OR ERBB2:L775_T759del OR ERBB2:G776delinsVC OR ERBB2:G776delinsVV OR ERBB2:G776delinsLC OR ERBB2:V777L OR ERBB2:G778_P780dup OR ERBB2:V779A OR ERBB2:V779L OR ERBB2:T798M OR ERBB2:L841V OR ERBB2:V842I OR ERBB2:N875S OR ERBB2:T862A OR ERBB2:L869A OR ERBB2:L869R OR ERBB2:H878Y OR ERBB2:R896C); *NOT_RECRUITING
NCT04589845	(sensitive_to_drug_class:pan-AKT_inhibitor OR sensitive_to:Ipatasertib); (AKT1:E17K OR AKT1:L52R OR AKT1:Q79K); *NOT prior_therapy:AKT_inhibitor; *NOT_RECRUITING
NCT04589845	(sensitive_to_drug_class:pan-AKT_inhibitor OR sensitive_to:Ipatasertib); (AKT3:E17K OR AKT3:L51R OR AKT3:Q78K); *NOT prior_therapy:AKT_inhibitor; *NOT_RECRUITING
NCT04589845	(sensitive_to_drug_class:pan-AKT_inhibitor OR sensitive_to:Ipatasertib); AKT2:E17K; *NOT prior_therapy:AKT_inhibitor; *NOT_RECRUITING
NCT04589845	COHORT_CLOSED; sensitive_to_drug_class:MDM2_inhibitor; MDM2:amplification; NOT TP53:oncogenic_mutation; catype:Liquid cancer; *NOT_RECRUITING
NCT04589845	sensitive_to:Alectinib; ALK:fusion; NOT catype:Non-small cell lung cancer; *NOT prior_therapy:ALK_inhibitor; *NOT ALK:I1171N; *NOT ALK:I1171S; *NOT ALK:G1202R
NCT04589845	sensitive_to:Entrectinib; (NTRK1:fusion OR NTRK2:fusion OR NTRK3:fusion); *NOT prior_therapy:NTRK_inhibitor
NCT04589845	sensitive_to:Entrectinib; ROS1:fusion; NOT catype:Non-small cell lung cancer; *NOT prior_therapy:ROS1_inhibitor
NCT04589845	sensitive_to_drug_class:ALK_inhibitor,second_generation; ALK:fusion; NOT catype:Non-small cell lung cancer; *NOT prior_therapy:ALK_inhibitor
NCT04589845	sensitive_to_drug_class:NTRK_inhibitor; (NTRK1:fusion OR NTRK2:fusion OR NTRK3:fusion); *NOT prior_therapy:NTRK_inhibitor
NCT04589845	(sensitive_to_drug_class:RAF_dimer_inhibitor OR sensitive_to:Belvarafenib); (BRAF:fusion OR BRAF:class_2_mutation OR BRAF:class_3_mutation); *NOT_RECRUITING
NCT04589845	sensitive_to_drug_class:ROS1_inhibitor; ROS1:fusion; NOT catype:Non-small cell lung cancer; *NOT prior_therapy:ROS1_inhibitor
NCT04589845	sensitive_to_drug_class:ROS1_inhibitor; ROS1:fusion; NOT catype:Non-small cell lung cancer; *NOT prior_therapy:ROS1_inhibitor
NCT04589845	tumour_mutational_burden:high; *NOT prior_therapy:immune_checkpoint_blockade; *NOT_RECRUITING
NCT04589845	(ATM:oncogenic_mutation OR ATM:deletion); *May not be recruiting
NCT04589845	(SETD2:oncogenic_mutation OR SETD2:deletion); *May not be recruiting
NCT04589845	KRAS:G12C; NOT catype:Non-small cell lung cancer; NOT catype:Colorectal cancer; *May not be recruiting
NCT04606446	(catype:Breast cancer OR catype:Prostate cancer OR catype:Non-small cell lung cancer)
NCT04607421	BRAF:V600E; catype:Colorectal cancer
NCT04624204	catype:Small-cell lung carcinoma
NCT04665206	(NF2:oncogenic_mutation OR NF2:alteration)
NCT04699188	KRAS:G12C
NCT04720768	(BRAF:V600E OR BRAF:V600K OR BRAF:V600_missense_mutation)
NCT04746924	NOT ALK:fusion; NOT EGFR:oncogenic_mutation
NCT04760288	RET:alteration
NCT04793958	KRAS:G12C; catype:Colorectal adenocarcinoma
NCT04857372	catype:Mesothelioma
NCT04857372	catype:Solid tumour; (YAP1:fision OR NF2:oncogenic_mutation)
NCT04895358	NOT ERBB2:amplification; NOT ERBB2:overexpression
NCT04969887	(catype:Biliary tract cancer OR catype:Gallbladder cancer OR catype:Cholangiocarcinoma); *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-L1_monoclonal_antibody
NCT04969887	(catype:Lung neuroendocrine tumour OR catype:Neuroendocrine carcinoma); NOT catype:Small-cell lung carcinoma; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-L1_monoclonal_antibody
NCT04969887	catype:Gynaecological cancer; (catype:Ovarian Clear Cell Carcinoma OR catype:Uterine Clear Cell Carcinoma OR catype:Uterine carcinosarcoma OR catype:Ovarian carcinosarcoma OR catype:Uterine leiomyosarcoma OR catype:Carcinosarcoma OR catype:Uterine carcinosarcoma OR catype:Vaginal cancer OR catype:Vulvar cancer); *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-L1_monoclonal_antibody; *(catype:Ovarian Clear Cell Carcinoma OR catype:Uterine Clear Cell Carcinoma)
NCT04969887	microsatellite_instability:high; NOT catype:Colorectal cancer; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-L1_monoclonal_antibody
NCT04969887	mismatch_repair:deficient; NOT catype:Colorectal cancer; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody + anti-PD-L1_monoclonal_antibody
NCT04956640	KRAS:G12C; *NOT prior_therapy:KRAS_G12C_inhibitor
NCT04913285	(BRAF:oncogenic_mutation OR NRAS:oncogenic_mutation); NOT_RECRUITING
NCT05067283	KRAS:G12C
NCT05150236	catype:Prostate cancer
NCT05288166	catype:Prostate cancer
NCT05059522	prior_therapy:Avelumab
NCT03611868	(catype:Melanoma OR catype:Malignant peripheral nerve sheath tumor)
NCT05217446	BRAF:V600E; (microsatellite_instability:high OR mismatch_repair:deficient)
NCT03900442	(catype:Multiple myeloma OR catype:Peripheral T-cell lymphoma OR catype:Colorectal cancer OR catype:Pancreatic adenocarcinoma); *Unknown status
NCT03900442	catype:Gastric cancer; *catype:Diffuse gastric cancer; *Unknown status
NCT05182931	(BRAF:V600E OR NRAS:oncogenic_mutation)
NCT05152147	(ERBB2:amplification OR ERBB2:overexpression)
NCT05364073	catype:Non-small cell lung cancer
NCT05311176	(catype:Gastroesophageal junction adenocarcinoma OR Gastroesophageal adenocarcinoma OR catype:Gastric Cancer); *(ERBB2:overexpression OR ERBB2:amplification); *prior_therapy:Trastuzumab
NCT05440786	catype:Ewings sarcoma
NCT03400332	NOT catype:Central nervous system cancer
NCT05176509	NOT catype:Central nervous system cancer
NCT05315700	NOT EGFR:T790M; (EGFR:exon_20_insertion OR ERBB2:exon_20_insertion OR ERBB2:amplification OR ERBB2:overexpression)
NCT05187624	EGFR:vIII
NCT05307705	PIK3CA:H1047R
NCT05269316	NOT catype:Central nervous system cancer
NCT05253651	(ERBB2:amplification OR ERBB2:overexpression)
NCT05480865	KRAS:G12C
NCT05425940	catype:Colorectal cancer
NCT05609370	catype:Colorectal cancer; NOT MSI:high; NOT MMR:deficient
NCT02513849	catype:Oesophageal cancer
NCT04631731	*BIOMARKER_STUDY
NCT05512377	MDM2:amplification; NOT TP53:oncogenic_mutation; (catype:Biliary tract cancer OR catype:Pancreatic adenocarcinoma OR catype:Urothelial carcinoma OR catype:Lung adenocarcinoma)
NCT04886804	NRG1:fusion
NCT04886804	ERBB2:overexpression
NCT04886804	ERBB2:amplification
NCT04886804	ERBB2:oncogenic_mutation; catype:Non-small cell lung cancer
NCT05614739	FGFR3:alteration
NCT04650581	NOT prior_therapy:Fulvestrant; NOT prior_therapy:selective_estrogen_receptor_degrader; NOT prior_therapy:PI3K_inhibitor; NOT prior_therapy:AKT_inhibitor; NOT prior_therapy:mTOR_inhibitor
NCT05501886	NOT prior_therapy:PI3K_inhibitor; NOT prior_therapy:AKT_inhibitor; NOT prior_therapy:mTOR_inhibitor
NCT05555732	*NOT prior_therapy:systemic_therapy; catype:Non-squamous non-small cell lung cancer
NCT05384626	(ALK:oncogenic_mutation OR ALK:fusion)
NCT05789082	KRAS:G12C
NCT04819100	RET:fusion
NCT04685135	KRAS:G12C; NOT prior_therapy:KRAS_G12C_inhibitor
NCT05654623	NOT prior_therapy:ARV-471; NOT prior_therapy:Fulvestrant; NOT prior_therapy:mTOR_inhibitor; NOT prior_therapy:PI3K_inhibitor; NOT prior_therapy:AKT_inhibitor; NOT prior_therapy:PARP_inhibitor
NCT04862663	NOT prior_therapy:selective_estrogen_receptor_degrader; *NOT prior_therapy:CDK4/6_inhibitor; NOT prior_therapy:mTOR_inhibitor; NOT prior_therapy:PI3K_inhibitor; NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:Fulvestrant; *NOT prior_therapy:selective_estrogen_receptor_degrader; *NOT prior_therapy:PI3K_inhibitor; *NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:mTOR_inhibitor
NCT04975308	catype:Breast cancer; NOT prior_therapy:selective_estrogen_receptor_degrader; NOT prior_therapy:mTOR_inhibitor; NOT prior_therapy:PI3K_inhibitor; NOT prior_therapy:AKT_inhibitor; *prior_therapy:aromatase_inhibitor
NCT05501886	NOT prior_therapy:selective_estrogen_receptor_degrader; NOT prior_therapy:mTOR_inhibitor; NOT prior_therapy:PI3K_inhibitor; NOT prior_therapy:AKT_inhibitor
NCT05118789	ROS1:fusion
NCT04835805	NRAS:oncogenic_mutation
NCT05338970	EGFR:oncogenic_mutation
NCT04771130	*NOT prior_therapy:BCL2_inhibitor; *NOT prior_therapy:Azacitidine
NCT05910827	NOT KRAS:oncogenic_mutation; NOT PIK3CA:oncogenic_mutation; NOT BRAF:oncogenic_mutation; NOT PTEN:deletion; NOT PTEN:oncogenic_mutation; NOT MET:amplification; catype:Lung squamous cell carcinoma; NOT prior_therapy:docetaxel; NOT prior_therapy:cetuximab; NOT prior_therapy:anti-HER3_monoclonal_antibody
NCT05286801	(SMARCB1:loss OR SMARCB1:oncogenic_mutation OR SMARCB1:loss of protein expression OR SMARCA4:loss OR SMARCA4:oncogenic_mutation OR SMARCA4:loss of protein expression); *PAEDIATRIC_TRIAL
NCT05646862	PIK3CA:oncogenic_mutation; NOT ERBB2:amplification; catype:Breast cancer; NOT catype:HER2-positive breast cancer
NCT04879329	*HER2:positive; *ERBB2:protein_expression; *ERBB2:overexpression
NCT04789096	*HER2:positive; *ERBB2:protein_expression; *ERBB2:overexpression
NCT04924075	*NOT KIT:oncogenic_mutation; *NOT PDGFRB:oncogenic_mutation; catype:Gastrointestinal stromal tumour
NCT04924075	catype:Solid tumour; (EPAS1:alteration OR FH:alteration OR SDHA:alteration OR SDHB:alteration OR SDHC:alteration OR SDHD:alteration OR SDHAF2:alteration OR EGLN1:alteration OR EGLN:alteration OR MDH2:alteration OR ELOC:alteration OR TCEB1:alteration); *NOT VHL:oncogenic_mutation
NCT05261399	catype:Non-small cell lung cancer; EGFR:oncogenic_mutation; *NOT prior_therapy:Osimertinib
NCT05876754	catype:Cholangiocarcinoma; IDH1:R132_mutation
NCT05043090	catype:Papillary renal cell carcinoma
NCT05487235	catype:Solid tumour; sensitive_to:GDC-1971
NCT05487235	catype:Non-small cell lung cancer; *sensitive_to:GDC-1971
NCT05487235	catype:Head and neck squamous cell carcinoma; *sensitive_to:GDC-1971
NCT05487235	catype:Melanoma; NOT BRAF:oncogenic_mutation; *sensitive_to:GDC-1971
NCT05919537	NRG1:fusion
NCT05743036	BRAF:V600E; catype:Colorectal cancer
NCT05611931	NOT TP53:oncogenic_mutation
NCT05647122	catype:Non-small cell lung cancer; EGFR:oncogenic_mutation
NCT05647122	catype:Non-small cell lung cancer; NOT EGFR:oncogenic_mutation
NCT05647122	catype:Head and neck squamous cell carcinoma
NCT04928846	NOT EGFR:oncogenic_mutation; catype:Non-small cell lung cancer
NCT05245968	catype:Gastrointestinal stromal tumour
NCT05383352	catype:Pancreatic adenocarcinoma
NCT05759728	catype:Colorectal adenocarcinoma
NCT05513703	catype:Non-small cell lung cancer; NOT catype:Lung squamous cell carcinoma; NOT EGFR:oncogenic_mutation; NOT ALK:fusion; NOT ROS1:fusion; NOT BRAF:oncogenic_mutation; *NOT prior_therapy:systemic_therapy; *MET:amplification
NCT05338970	catype:Non-squamous non-small cell lung cancer; (EGFR:L858R OR EGFR:exon_19_deletion)
ACTRN12620001146987	*NOT_RECRUITING
NCT04976634	catype:Hepatocellular carcinoma
NCT04976634	catype:Colorectal adenocarcinoma; NOT microsatellite:instable; NOT mismatch_repair:deficient
NCT04976634	catype:Pancreatic adenocarcinoma
NCT04976634	catype:Biliary tract adenocarcinoma
NCT04976634	catype:Endometrial cancer
NCT04976634	catype:Oesophageal squamous cell carcinoma
ACTRN12623000223639	catype:Pancreatic adenocarcinoma
NCT03833154	catype:Non-small cell lung cancer; EGFR:oncogenic_mutation
NCT04612751	NOT prior_therapy:systemic_therapy
NCT04612751	NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT05555732	NOT EGFR:oncogenic_mutation; NOT ALK:fusion; NOT ROS1:fusion; NOT NTRK1:fusion; NOT NTRK2:fusion; NOT NTRK3:fusion; NOT BRAF:V600E; NOT BRAF:class_2_mutation; NOT BRAF:class_3_mutation; NOT RET:fusion; NOT MET:exon_14_skipping_mutation; NOT prior_therapy:systemic_therapy; NOT prior_therapy:anti-Trop2_monoclonal_antibody; NOT prior_therapy:anti-PD-1_monoclonal_antibody; NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT05855200	catype:Colorectal adenocarcinoma; *catype:Colon adenocarcinoma
NCT05328908	catype:Colorectal adenocarcinoma
NCT04305249	*sensitive_to:ATG-017
NCT04985721	*sensitive_to:Pamiparib
NCT05067283	catype:Solid tumour; NOT catype:Non-small cell lung cancer; KRAS:G12C; prior_therapy:systemic_therapy
NCT05067283	catype:Non-small cell lung cancer; NOT prior_therapy:systemic_therapy; KRAS:G12C
NCT05067283	catype:Colorectal cancer; NOT prior_therapy:systemic_therapy; KRAS:G12C
NCT05919537	(ERBB3:V104M OR ERBB3:V104L OR ERBB3:G284R OR ERBB3:D297Y OR ERBB3:D297V OR ERBB3:A232V); NOT KRAS:oncogenic_mutation; NOT PIK3CA:oncogenic_mutation; NOT BRAF:oncogenic_mutation; NOT PTEN:deletion; NOT PTEN:oncogenic_mutation; NOT MET:amplification
NCT05498428	catype:Non-small cell lung cancer; (EGFR:exon_19_deletion OR EGFR:L858R OR EGFR:exon_20_insertion)
NCT04985604	(KRAS:oncogenic_mutation OR NRAS:oncogenic_mutation OR HRAS:oncogenic_mutation OR BRAF:oncogenic_mutation OR MAP2K1:oncogenic_mutation OR NF1:oncogenic_mutation OR RAF1:fusion OR RAF1:amplification)
NCT05580770	catype:Melanoma; NRAS:oncogenic_mutation
NCT05580770	catype:Non-small cell lung cancer; KRAS:oncogenic_mutation
NCT05580770	(catype:Non-small cell lung cancer OR catype:Melanoma); (BRAF:class_2_mutation OR BRAF:class_3_mutation)
NCT04985721	(ATM:oncogenic_mutation OR CDK12:oncogenic_mutation OR PALB2:oncogenic_mutation OR ARID1A:oncogenic_mutation OR ATRX:oncogenic_mutation OR BLM:oncogenic_mutation OR BARD1:oncogenic_mutation OR BRIP1:oncogenic_mutation OR CHEK1:oncogenic_mutation OR CHEK2:oncogenic_mutation OR FANCA:oncogenic_mutation OR FANCF:oncogenic_mutation OR FANCG:oncogenic_mutation OR FANCI:oncogenic_mutation OR FANCL:oncogenic_mutation OR FANCM:oncogenic_mutation OR MSH2:oncogenic_mutation OR NBN:oncogenic_mutation OR RAD50:oncogenic_mutation OR RAD51C:oncogenic_mutation OR RAD51D:oncogenic_mutation OR WRN:oncogenic_mutation OR mutational_signature:SBS3 OR loss_of_heterozygozity_score:high OR homologous_recombination_score:high)
NCT04985721	(BRCA1:oncogenic_mutation OR BRCA2:oncogenic_mutation)
NCT05919537	NRG1:fusion
NCT05919537	NOT NRG1:fusion; ERBB3:oncogenic_mutation; *(ERBB3:V104M OR ERBB3:V104L OR ERBB3:G284R OR ERBB3:D297V OR ERBB3:D297Y OR ERBB3:A232V); *NOT KRAS:oncogenic_mutation; *NOT PIK3CA:oncogenic_mutation; *NOT BRAF:oncogenic_mutation; *NOT PTEN:oncogenic_mutation; *NOT PTEN:loss; *NOT MET:amplification
NCT05694936	*NOT prior_therapy:systemic_therapy
NCT03900884	*NOT prior_therapy:CDK4/6_inhibitor
NCT05894239	PIK3CA:oncogenic_mutation; *(ERBB2:amplification OR ERBB2:overexpression)
NCT05872295	catype:Breast cancer; *(ERBB2:amplification OR ERBB2:overexpression OR ERBB2:low_protein_expression)
NCT05872295	(catype:Gastric cancer OR catype:Gastroesophageal adenocarcinoma); *(ERBB2:amplification OR ERBB2:overexpression OR ERBB2:low_protein_expression); prior_therapy:systemic_therapy
NCT05872295	catype:Solid tumour; NOT Breast cancer; NOT Gastric cancer; NOT Gastroesophageal adenocarcinoma; *(ERBB2:amplification OR ERBB2:overexpression OR ERBB2:low_protein_expression OR ERBB2:oncogenic_mutation)
NCT05577416	NOT prior_therapy:systemic_therapy
NCT04929223	catype:Colorectal adenocarcinoma; (*microsatellite_instability:high OR *mismatch_repair:deficient)
NCT04895709	*NOT prior_therapy:Docetaxel
NCT05348577	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:AKT_inhibitor
NCT05544552	FGFR3:alteration
NCT04670679	*NOT PTPN11:oncogenic_mutation; *NOT prior_therapy:SHP2_inhibitor
NCT06024174	KRAS:G12C
NCT04802759	catype:Breast cancer; *ESR1:protein_expresion
NCT04802759	catype:Breast cancer; *ESR1:protein_expresion; *(ERBB2:amplification OR ERBB2:overexpression OR ERBB2:low_protein_expression)
NCT04802759	catype:Breast cancer; *ESR1:protein_expresion; sensitive_to:Ipatasertib; *NOT prior_therapy:AKT_inhibitor
NCT04802759	catype:Breast cancer; *ESR1:protein_expresion; sensitive_to:Inavolisib; *NOT prior_therapy:AKT_inhibitor; *NOT prior_therapy:PI3K_alpha_inhibitor; *NOT prior_therapy:MTOR_inhibitor
NCT04802759	catype:Breast cancer; *ESR1:protein_expresion; *NOT prior_therapy:MTOR_inhibitor
NCT04802759	catype:Breast cancer; *ESR1:protein_expresion; sensitive_to:Atezolizumab; *NOT prior_therapy:anti-CD137_agonistic_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT05417594	*(BRCA1:oncogenic_mutation OR BRCA2:oncogenic_mutation OR PALB2:oncogenic_mutation OR RAD51C:oncogenic_mutation OR RAD51D:oncogenic_mutation)
NCT05954871	catype:Colorectal cancer; NOT KRAS:oncogenic_mutation; NOT BRAF:V600E; NOT NRAS:oncogenic_mutation
NCT05954871	catype:Non-small-cell lung cancer; (EGFR:L858R OR EGFR:exon_19_deletion)
NCT05920356	KRAS:G12C
NCT06119581	KRAS:G12C
NCT05462717	KRAS:G12C
